This study is currently not recruiting new participants. Add it to your favourites and check back later.
Clinical Trial

Functional Assessment Implantable Cardioverter Defibrillator

Study Description

Clinical and Device Functional Assessment of Real World ICD Patients

The primary requirement of the implantable cardioverter defibrillator (ICD) is to preserve life by terminating life-threatening arrhythmias (VT/VF). The treatment options vary in terms of techniques and medical devices, based on the patient's condition. It is extremely important in the clinical practice to identify which patients' subgroup benefits the most from the ICD therapy, which comorbidity has a major impact on the patients' prognosis, or which pre-intra-post procedural behaviors provoke less complications, and affect the patient's outcome (including prolonged or unwanted hospitalizations).

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Device - ICD

ICD single, dual or triple chamber, upgrade, replacement or primo implant

Additional Information

Official Study Title

Clinical and Device Functional Assessment of Real World ICD Patients

Clinical Trial ID

NCT02341768

ParticipAid ID

1aKYld